Ann Rheum Dis

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by WENDLING, D
Right arrow Articles by RACADOT, E
Right arrow Search for Related Content
PubMed
Right arrow Articles by WENDLING, D
Right arrow Articles by RACADOT, E
Ann Rheum Dis 2000;59:574 ( July )

Letters to the editor

Lack of involvement of the Fas system in ankylosing spondylitis

The first 150 words of the full text of this article appear below.

Apoptosis or programmed cell death is one of the regulation mechanisms of cell homeostasis.

Fas is a transmembrane receptor protein which transmits a cell death signal when cross linked with an antibody or with its physiological ligand---Fas ligand (Fas L).1 Fas and Fas L have a pivotal role in regulating lymphocyte apoptosis and maintaining lymphocyte homeostasis.

Soluble forms of Fas and Fas L may be detectable and measured in the serum,2 and may reflect the activation of this pathway. Moreover, soluble forms of Fas regulate Fas/Fas L mediated apoptosis.3 Raised levels of soluble Fas (sFas) have been shown in various chronic inflammatory rheumatic diseases, systemic lupus erythematosus, Sjögren's syndrome,1 4 5 and in the synovial fluid of rheumatoid arthritis.6 These diseases are autoimmune diseases with lymphocyte involvement.

Ankylosing spondylitis (AS) is another chronic inflammatory rheumatic disorder, with less autoimmune background or lymphocyte involvement. Involvement of apoptosis in the pathogenesis of AS . . . [Full text of this article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2000 BMJ Publishing Group Ltd & European League Against Rheumatism